A Study of LY4065967 in Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fortrea Clinical Research Unit, Daytona Beach, Florida, United States
Study coordinator · 386-366-6400
Contact: Principal Investigator (Hugh Coleman)
Fortrea Clinical Research Unit, Dallas, Texas, United States

Study leads

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

Temporal Interference for Thalamocortical Activity and Network Modulation

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Madison, United States

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Madison, United States

Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

Healthy Volunteer Study

Abroad (travel likely)RecruitingPHASE1

Boston, United States